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ABSTRACT
Our objective was to investigate patient knowledge, desire for participation in medical decision making, and preference for the management of mildly abnormal Papanicolaou (Pap)
smears (low-grade squamous intraepitheliallesions [LGSIL]) in the context of the continuing
controversy between active (immediate colposcopy and biopsy) and surveillance (repeat Pap
smears) management strategies. One hundred thirty-six women referred for a diagnostic col. poscopy ~ith a first-time mildly abnormal Pap smear result completed questionnaires before
contad with either the nurse or physician. They were given the State-Trait Anxiety Inventory, the CESD Depression scale, and a knowledge about dysplasia quiz. They were then presentedwith the
management options and asked to state a preference, if any. They then
completed the Problem Solving-Decision Making Scale, a measure of desire for involvement
in medical decision making. The majority of women in this sample opted for the active man. agement,strategy. Management preference was related to anxiety, with the most anxious
women more likely to choose the active management strategy. Management preference was
not related to knowledge or to desire for an active role in decision making, although the more
knowledgeable women also reported a desire for an active role in the decision-making
process. Given the current controversy over the management of mildly abnormal Pap smears
(LGSIL), as well as the fact that there is no conclusive evidence to support one strategy over
another, the informed management preference of women affected by these decisions should
be factored into the equation.

two

INTRODUCTION
LTHOUGH THERE IS A NEAR CONSENSUS that
women with moderate to severe cervical
dysplasia (high-grade squamous epithelial lesions [HGSIL]) on a Papanicolau (Pap) smear

A

should be evaluated and treated immediately if
the degree of HGSIL is confirmed, the appropriate management of borderline abnormalities,
such as squamous atypia and low-grade dysplasia [low-grade[LG] SILl CIN 1), remains controversial. The controversy centers on two opposing
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·:,inariagementst~ategies. One strategy is based on
· ,· cytologisalsurveillance_ ~repeat Pap smears) un-

;, tipow-grade abnormahhes revert to normal, re'serving histological evaluation and biopsy only
for those abnormalities that persist or progress to
higher grades. The alternative s_trategy is _to refer
all abnormalities for colposcoptc evaluation and
biopsy immediately. As recently as 1993, a nationwide (U.S.) survey of physicians showed that
40%-45% recommend early colposcopy and
biopsy in patients with atypical squamous cells
of undetermined significance on Pap smear,
:~whereas the rest of the respondents favored a less
· aggressive approach.1 Clinical guidelines in the
.. United States and Canada have at times favored
::a cytological surveillance strategy with atypia
' 'and low-grade abnormalities.2'3 The 1992 Na,•,tional Cancer Institute (NCI) Workshop interim
; guidelines for the management of abnormal cer' · vical cytology suggested that women with low.. grade Pap smear may be followed by repeat Pap
'smear. 2 On the other hand, the 1993 American
College of Obstetricians and Gynecologists Technical Bulletin 183 on the evaluation and management of cervical cytology abnormalities recommended either proceeding directly to colposcopy
for LGSIL orusing the "conservative approach"
for patients who are "carefully selected and considered reliable for follow-up." 4 Clearly, there is
a lack of consensus on which is the most appropriat~ strategy.
. ··
. The surveillance strategy is based on the belief
that the majority of cervical abnormalities will revert;~o.~ormal spontaneously and that, even in
the min()r~ty of the cases that progress, progression is generally slow.s-7 The argument further
that reserving colposcopic referral for persistent or progressive abnormal smears would result in a significant reduction in healthcare expenditures and would ;lessen the anxiety often
evidenced in' women ·.undergoing these proce'dures:~lO Proponents of the active strategy pri'marily argue that we do not understand sufficiently the factors that influence the progression
oi remission of mild· abnormalities to forego histological evaluation.tThey further suggest that (1)
a significant riumber:ofmildly abnormal smears
have underlying higher grade dysplasia, (2) patient noncompliance with follow-up Pap smears
would increase the risk 6fcervical carcinoma, (3)
financial costs would ultimately be equivalent, as
many of these women would eventually require
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colposcopic evaluation, and (4) the wait wo~ld
result in increased anxiety for the women mvolved.l1-13
There are strong arguments in favor of either
strategy, but there is no clear-cut evi~ence indicating that one management strategy IS necessarily better than the other, which is precisely why
the controversy persists. 11,14 In the absence of results from a randomized clinical trial that could
possibly settle the issue, clinicians must continue
to make decisions and recommend strategies to
their patients.
The management of mildly abnormal Pap
smears is an important women's health issue, as
5%-10% of the more than 28 million Pap smears
performed in the United States every year are
evaluated to be abnormal, and 95% of these abnormalities are low-grade abnormalities. This
means that at least 1.33 million women in the
United States alone are affected by these decisions on a yearly basis. 11 Considering the large
number of women affected and the lack of overwhelming evidence to support one strategy over
another, it seems curious that patient preference
has only rarely been mentioned as a variable worthy of further study or of incorporation into medical decision making_l1,12
This study sought to investigate management
preference and desire for decision-making involvement in women who have received a first
mildly abnormal Pap smear result. Of secondary
interest was the extent to which management
preference and desire for involvement in decision
making were related to psychological distress
and knowledge about their condition and the procedures involved in the evaluation and management of borderline cervical abnormalities.

MATERIALS AND METHODS
Consecutive English-speaking women with a
first-time mildly abnormal Pap smear (atypia,
human papillomavirus [HPV] effects, LGSIL) referred to a metropolitan clinic for a diagnostic colposcopy were approached immediately after registration and before contact with either a nurse or
the physician. They were asked if they would be
willing to complete a series of questionnaires.
Consenting women were given a short package
of questionnaires that they were instructed to
complete in a predetermined order before contact
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with any health professional. The research assistant was nearby to answer questions they might
have while completing the study packet. The
study protocol was approved by the Ethics Review Board of The Toronto Hospital.
The first questionnaire in the packet inquired
about age, educational level, marital status, number of children, the type of doctor who referred
them, whether they had known anyone who had
had a colposcopy, and whether they had ever
read an article or seen I heard a TV I radio segment
on Pap smears. Women then completed the StateTrait Anxiety Inventory (STAI), 15 a 40-item selfreport scale that measures state and trait levels of
anxiety reliably, and the Center for Epidemiological Studies Scale for Depression (CESD), a 20item self-report scale that screens for the presence
of depression in the general population. 16 These
were followed by a knowledge quiz, adapted
from Stewart et al., 17 that required women to
circle answers in a multiple choice format for
eight questions regarding cervical dysplasia, colposcopy, management options, and follow-up
regimens. Patient preference was determined by
presenting women with a description of the two
opposing management strategies, preceded by a
statement stating that neither had been proved
superior at curtailing the development of cervical cancer. They were then asked to choose the
management strategy they preferred or to indicate that they had no strong preference for either
strategy. Finally, women were asked to complete
the Problem-Solving Decision-Making Scale
(PSDM), 18 which is a psychometrically sound
scale that presents patients with six questions
about who should determine diagnosis, treatment options, risks and benefits, probabilities,
utilities, and what should be done. The two factors that emerge from this measure are problem
solving (the first four questions) and decision
making (the last two questions). The scale scores
are 1 = "doctor alone," 2 = "mostly the doctor,"
3 = "the doctor and you equally," 4 = "mostly
you," 5 = "you alone."
Univariate analyses of variance (ANOVA)
were used to probe for differences between the
management preference groups on psychological
distress variables, knowledge, and problem-solving decision-making variables. Pearson correlations were used to probe for relationships between psychological distress and knowledge and
decision-making variables. Finally, chi-square

analyses were performed for discrete variables to
test for management group differences. Sample
size was set for a power of 0.80 in detecting
medium size effects at p = 0.05.

RESULTS
One hundred forty-five consecutive women
were approached. Four refused and five did not
have time to complete the questionnaire before
their diagnostic colposcopic examination. Thus,
136 women signed the consent form and completed the questionnaires. The mean (::!:: standard
deviation [SD]) age of the sample was 33.40 :!::
10.81 years. The educational level of the sample
was primary school in 2 (1.5% ), high school in 29
(21.3%), postsecondary school in 86 (63.2%), and
postgraduate study in 19 (14%). Sixty-two women
(45.6%) were single, 13 (9.6%) were separated/ di·
vorced, 60 (44.1%) were married I cohabiting, and
1 (0.7%) was widowed. Thirty-eight (27.9%) had
a Pap result of atypia, 86 (63.2%) had LGSIL/CIN
I, and 12 (8.8%) had HPV effects. Twenty·six
(19.1%) women had been referred by their gynecologist, 96 (70.6%) by their primary care physician, and 14 (10.3%) by someone other than their
gynecologist or family doctor.
In terms of psychological distress, the mean for
depressive symptomatology on the CESD was
11.62 (::!::8.45), which is well below the score of 16
at which depressive symptomatology is considered significant. Ninety·eight women (72'Yc))
scored below 16, and 38 (28%) could be considered to be significantly depressed. The mean for
state anxiety was 43.46 (:!::10.14), which is considered a moderate level of anxiety in comparison to norms. Eleven women (8.2%) reported
very little state anxiety, 40 (29.9%) reported mild
levels of state anxiety, 69 (59.7%) reported mod·
erate levels of state anxiety and 14 (10.4%)
reported severe to very severe anxiety. The mean
for trait anxiety was 37.24 {:!::9.53), which is considered a mild level of anxiety. The difference between state anxiety and trait anxiety was signifi·
cant (T2 =7.33, df = 133, p =0.0001), indicating
that women perceived themselves to be significantly more anxious just prior to colposcopy than
they regularly felt.
In terms of knowledge about dysplasia, col·
poscopy, management options, and follow-up
regimens, the mean score on the quiz (8 being a
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1.

CoRRECT REsPONSE FREQUENCIES FOR DYSPLASIA KNOWLEDGE

QUiz

Correct responses
(n = 136)

Knowledge of
What abnormal Pap smear results from
The type of abnormality f.ou~d o~ personal Pap test
What a colposcopic exammahon IS
Smoking as a risk factor
Unprotected sex as a risk factor
Management options
Progression likelihood if untreated
Follow-up recommendations

perfect score) was 3.40 (±1.87). Knowledge was
lowest regarding smoking as a risk factor for cervical dysplasia (15% were aware) and what the
follow-up recommendations are for abnormal
·Pap results (13% were aware), but approximately
50% of women were unable to correctly respond
to most other questions (Table 1). Women who
· reported they knew someone who had undergone a colposcopy scored significantly higher on
.the knowledge quiz than women who did not (F
:,·(1,132) = 12.34, p = 0.001). The same was true for
, women who had been exposed to media cover,age of Pap smears (F (1,132) = 21.46, p = 0.0001)
When·pn~sented with the two opposing management strategies and the declaration that there
was rio solid evidence to support one strategy
over another, the majority of women chose the
,histological evaluation and likely biopsy option
·(active strategy). Eighty-seven (64%) stated that
they preferred the active strategy, 24 (17%) stated
~ preferencedor the cytological surveillance strat~gy, and 23(17%) stated that they had no strong
pref~~encefor either management option.

n

%

74

54.4
46.3
46.3
15.4
48.5

63
63

21
66

69
86
18

50.7
63.2
13.2

In terms of problem solving and decision making, the women in this sample responded similarly to other patient groups18 in that they preferred to leave the diagnosis, determination of
treatment options, and determination and probability estimates of treatment risks and benefits
mostly to the physician (problem solving mean
was 2.08 ± 0.53), but they want to be more involved in the estimation of utilities (the value
placed on risks and benefits) and the final decision (decision making mean was 3.27 ± 0.92
(Figs. 1, 2, 3, 4, 5, and 6).
There were two main significant relationships
between measures. Management preference was
related to state anxiety when state anxiety was
treated as a discrete variable. Women reporting
moderate to severe anxiety were more likely to
choose the active management strategy than
women who only reported very little to mild anxiety (x2 (1,134) = 3.64, p = 0.05). Management
preference was not related to knowledge about
dysplasia nor to level of participation desired in
medical decision making. Score on the knowl100
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FIG. 1.' ·Who should determine if your Pap smear is abnormal?
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FIG. 2. Who should determine what the treatment options are?
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FIG. 3. Who should determine what the risks and benefits for each treatment option are?

FIG. 5. Given the risks and benefits of these possible
treatments, who should determine how acceptable those
risks and benefits are to you?

edge quiz correlated positively with the desire for
a more active role in decision making (r = .26, p =

strategies and more time to reflect. On the other
hand, our brief presentation of the management
options may reflect more accurately what may
transpire during a consultation with the referring
physician.
Furthermore, management preference in this
sample was not related to knowledge but rather
to level of state anxiety. This indicates that these
decisions may be guided more by emotions than
by facts. Research has shown repeatedly that abnormal Pap smears are associated with a signifi·
cant amount of anxiety. 19 It could be that fear
of invasive carcinoma weighs in heavily on the
side of the active management strategy, despite
knowledge of its being a low probability event. It
would not be the first time that the emotional valence of a low-probability outcome outweighs
that of a high-probability and just as serious alternative. Women's fear of breast cancer, associated in very low numbers with hormone rc·

0.002).

DISCUSSION
The majority of women in this highly educated
sample preferred active management (histological evaluation) of their mildly abnormal Pap
smears, although a substantial minority either
opted for the surveillance strategy (cytological
surveillance) or reported no strong preference.
Considering that half of them were completely
unaware of appropriate management strategies
before our brief presentation of their options,
these results constitute an on-the-spot decision
based on little information and time. Preferences
may have been different if women were given
more details about the different management
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FIG. 4. Who should determine how likely each of the
risks and benefits is to happen?
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FIG. 6. Given all the information about risks and benefits of the possible treatments, who should decide which
treatment option should be selected?
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a more active strategy before their participation i.n
placement therapy (HRT), has consist~ntly ?:en
our study. This seems unlikely, however, ~s this
shown to have a greater impact on the1r decision
making than the much higher risk of coronary sample had minimal knowledge of dysplasia, colheart disease (CHD) when HRT is not adhered to poscopy, and management options. ~ver half of
after menopause. 20 Information has been shown them had no idea what a colposcopy IS, and half
to decrease anxiety related to abnormal Pap of them were unaware of management strategies.
smears,17 but it is currently unclear how that There is, consequently, little evidence that the
might affect patient preference for management women were informed in any particular direction.
strategies. Knowledge is clearly not a factor that Future studies could investigate the management
has determined on which side of the controversy preference of women before any diagnostic referthe myriad medical researchers investigating this ral, as well the preferences of less well educated
women. As this study was conducted in Canada,
issue stand.
This sample had a high educational level, with its socialized healthcare, direct financial costs
which may be in part due to the clinic's proxim- were not a factor in the management preferences
ity to the university. It would be expected that of the women in this sample. An analogous study
the high educational level of this sample might in the United States would be needed to investiresult in higher levels of knowledge about dys- gate the extent to which financial concerns would
plasia than in the general population. Yet knowl- affect women's preferences for the management of
edge of dysplasia and colposcopy was low. Half Pap smear results.
of the women were ignorant of some of the most
As gynecologists continue to evaluate the comelementary facts, such as the level of abnormal- parative medical efficacy of different strategies in
. ity indicated by the Pap smear and the most the management of low-grade cervical abnorbasic information about the procedure they malities, it seems important that patient preferwere about to undergo. These results are not ence and psychosocial factors affecting preferinconsistent with other studies on women's ence be integrated into the evaluation process and
knowledge of Pap smears and colposcopy proce- incorporated into clinical practice. Regardless of
dures.21·22 One study noted that the three ques- the management strategy preferred or adopted,
tions most important to women referred for col- adherence to both screening and treatment regiposcopy were: (1) What do the findings mean? (2) mens is requisite. The active participation of these
What is a colposcopy? (3) What will happen at patients in the management choice for their
the clinic? 23 Clearly, at least half of the women in mildly abnormal Pap smears has the potential to
this study did not have the answers to these ques- significantly affect adherence to both screening
tions before arriving at the colposcopy clinic. Also and treatment regimens. Provision of knowledge
consistent with previous research was the find- about dysplasia and its management will be a
ing . that women's perception of information part of the equation, as it has already been shown
gained through personal contacts and media to have a significant impact on follow-up rates. 24
sources had a significant impact on what they ac~ally knew. 21 Knowledge, however, was related
to desire for participation in the decision making
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